Cargando…

The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease

INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A muscul...

Descripción completa

Detalles Bibliográficos
Autores principales: Keskin, Onur, Farisogullari, Bayram, Yardimci, Gozde Kubra, Gurbuz, Burcu, Kole, Melike, Parlak, Erkan, Karadag, Omer, Kav, Taylan, Kalyoncu, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947339/
https://www.ncbi.nlm.nih.gov/pubmed/36844210
http://dx.doi.org/10.3389/fmed.2023.1115362
_version_ 1784892529941938176
author Keskin, Onur
Farisogullari, Bayram
Yardimci, Gozde Kubra
Gurbuz, Burcu
Kole, Melike
Parlak, Erkan
Karadag, Omer
Kav, Taylan
Kalyoncu, Umut
author_facet Keskin, Onur
Farisogullari, Bayram
Yardimci, Gozde Kubra
Gurbuz, Burcu
Kole, Melike
Parlak, Erkan
Karadag, Omer
Kav, Taylan
Kalyoncu, Umut
author_sort Keskin, Onur
collection PubMed
description INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A musculoskeletal symptom questionnaire was given to all patients with IBD during their follow-up examinations between January 2020 and November 2021. The DETAIL questionnaire consisting of six questions about the musculoskeletal system was administered by asking the patients with IBD. All patients who answered yes to at least one of these questions were directed to specialists in the rheumatology department to undergo a detailed examination. The patients who were diagnosed with rheumatological disease after further investigation were recorded. Patients with a known diagnosis of rheumatological disease were excluded from the study. FINDINGS: There were 333 patients with IBD included in the study. Of these patients, 41 (12.3%) had a previously diagnosed rheumatological disease and were excluded from the evaluation. Of the remaining 292 patients (147 with ulcerative colitis, 139 with Crohn’s disease and six with indeterminate colitis; mean age 42 years), 67 (23%) answered yes to at least one of the questions and were referred to a rheumatology consultation. Rheumatological examination was completed in 52 patients. As a result of the evaluations, 24 patients (8.2%) were diagnosed with enteropathic arthritis (14 axial, 9 peripheral, and 1 axial plus peripheral). Patients with newly diagnosed enteropathy had a lower median disease age than patients without enteropathy. CONCLUSION: The DETAIL questionnaire is an effective and easy tool for identifying missed cases of SpA in patients with IBD.
format Online
Article
Text
id pubmed-9947339
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99473392023-02-24 The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease Keskin, Onur Farisogullari, Bayram Yardimci, Gozde Kubra Gurbuz, Burcu Kole, Melike Parlak, Erkan Karadag, Omer Kav, Taylan Kalyoncu, Umut Front Med (Lausanne) Medicine INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A musculoskeletal symptom questionnaire was given to all patients with IBD during their follow-up examinations between January 2020 and November 2021. The DETAIL questionnaire consisting of six questions about the musculoskeletal system was administered by asking the patients with IBD. All patients who answered yes to at least one of these questions were directed to specialists in the rheumatology department to undergo a detailed examination. The patients who were diagnosed with rheumatological disease after further investigation were recorded. Patients with a known diagnosis of rheumatological disease were excluded from the study. FINDINGS: There were 333 patients with IBD included in the study. Of these patients, 41 (12.3%) had a previously diagnosed rheumatological disease and were excluded from the evaluation. Of the remaining 292 patients (147 with ulcerative colitis, 139 with Crohn’s disease and six with indeterminate colitis; mean age 42 years), 67 (23%) answered yes to at least one of the questions and were referred to a rheumatology consultation. Rheumatological examination was completed in 52 patients. As a result of the evaluations, 24 patients (8.2%) were diagnosed with enteropathic arthritis (14 axial, 9 peripheral, and 1 axial plus peripheral). Patients with newly diagnosed enteropathy had a lower median disease age than patients without enteropathy. CONCLUSION: The DETAIL questionnaire is an effective and easy tool for identifying missed cases of SpA in patients with IBD. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9947339/ /pubmed/36844210 http://dx.doi.org/10.3389/fmed.2023.1115362 Text en Copyright © 2023 Keskin, Farisogullari, Yardimci, Gurbuz, Kole, Parlak, Karadag, Kav and Kalyoncu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Keskin, Onur
Farisogullari, Bayram
Yardimci, Gozde Kubra
Gurbuz, Burcu
Kole, Melike
Parlak, Erkan
Karadag, Omer
Kav, Taylan
Kalyoncu, Umut
The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title_full The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title_fullStr The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title_full_unstemmed The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title_short The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
title_sort detail questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947339/
https://www.ncbi.nlm.nih.gov/pubmed/36844210
http://dx.doi.org/10.3389/fmed.2023.1115362
work_keys_str_mv AT keskinonur thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT farisogullaribayram thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT yardimcigozdekubra thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT gurbuzburcu thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kolemelike thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT parlakerkan thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT karadagomer thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kavtaylan thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kalyoncuumut thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT keskinonur detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT farisogullaribayram detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT yardimcigozdekubra detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT gurbuzburcu detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kolemelike detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT parlakerkan detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT karadagomer detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kavtaylan detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease
AT kalyoncuumut detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease